The Pulse interview: Dr. Thomas Madden (Acuitas Therapeutics)

The Pulse on CFRO ›

16:53 | Nov 10th, 2020

Today, David talks to the UBC scientist linked to the promising BioNTech COVID-19 vaccine, Dr. Thomas Madden (CEO of Acuitas Therapeutics) on the new breakthrough they say is 90% effective.